Add office photos
Employer?
Claim Account for FREE
Biocon Biologics
3.6
based on 834 Reviews
Video summary
Company Overview
Company Locations
Working at Biocon Biologics
Company Summary
Biocon Biologics is today one of the frontrunners in the global biosimilars industry, working to provide patients access to affordable biologics and enable health equity worldwide.
Overall Rating
3.6/5
based on 834 reviews
8% below
industry average
Critically rated for
Promotions, Work satisfaction, Work-life balance
Work Policy
Work from office
77% employees reported
Monday to Saturday
41% employees reported
Flexible timing
78% employees reported
No travel
61% employees reported
View detailed work policy
Top Employees Benefits
Health insurance
203 employees reported
Job/Soft skill training
200 employees reported
Cafeteria
164 employees reported
Free meal
114 employees reported
View all benefits
About Biocon Biologics
Founded in1978 (47 yrs old)
India Employee Count1k-5k
Global Employee Count1k-5k
India HeadquartersBangalore/Bengaluru, Karnataka, India
Office Locations
Websitebioconbiologics.com
Primary Industry
Other Industries
--
Are you managing Biocon Biologics's employer brand? To edit company information,
claim this page for free
View in video summary
Biocon Biologics is driven by a strong sense of purpose and the unwavering commitment to serve patients and healthcare systems across the globe by unlocking equitable access to high quality biosimilars.
Healthcare systems across the world are skewed towards serving the affluent, denying access to many. Biocon Biologics is challenging the status quo by putting ‘patients first’ to make a long-term social impact worldwide.
We are leveraging our affordable innovation model to reduce disparities in access to safe, high-quality medicines, as well as improve patient outcomes and provide global communities with differentiated, high-quality and affordable healthcare solutions.
Our business model seeks to make biologic therapies affordable, accessible and available to all, thereby benefiting patients and their families across the world.
Our roadmap for the future is to enable a healthier world.
Mission: To be an integrated biotechnology enterprise of global distinction.
Vision: To enhance global healthcare through innovative and affordable biopharmaceuticals for patients, partners and healthcare systems across the globe
Managing your company's employer brand?
Claim this Company Page for FREE
Biocon Biologics Ratings
based on 834 reviews
Overall Rating
3.6/5
How AmbitionBox ratings work?
5
270
4
252
3
160
2
66
1
86
Category Ratings
3.4
Company culture
3.4
Skill development
3.3
Job security
3.3
Salary
3.3
Work-life balance
3.2
Work satisfaction
2.9
Promotions
Biocon Biologics is rated 3.6 out of 5 stars on AmbitionBox, based on 834 company reviews.This rating reflects an average employee experience, indicating moderate satisfaction with the company’s work culture, benefits, and career growth opportunities. AmbitionBox gathers authentic employee reviews and ratings, making it a trusted platform for job seekers and employees in India.
Read more
Gender Based Ratings at Biocon Biologics
based on 804 reviews
3.4
Rated by 158 Women
Rated 3.3 for Job security and 3.2 for Company culture
3.6
Rated by 646 Men
Rated 3.5 for Company culture and 3.5 for Skill development
Work Policy at Biocon Biologics
based on 168 reviews in last 6 months
Work from office
77%
Hybrid
22%
Permanent work from home
1%
Biocon Biologics Reviews
Top mentions in Biocon Biologics Reviews
+ 5 more
Compare Biocon Biologics with Similar Companies
Change Company | Change Company | Change Company | ||
|---|---|---|---|---|
Overall Rating | 3.6/5 based on 834 reviews | 3.9/5 based on 1.9k reviews | 3.7/5 based on 711 reviews | 3.8/5 based on 839 reviews |
Highly Rated for | No highly rated category | Work-life balance Job security | No highly rated category | Job security Work-life balance Company culture |
Critically Rated for | Promotions Work satisfaction Work-life balance | Promotions | Promotions Job security | Promotions |
Primary Work Policy | Work from office 77% employees reported | Work from office 83% employees reported | Work from office 74% employees reported | Hybrid 49% employees reported |
Rating by Women Employees | 3.4 Average rated by 158 women | 3.9 Good rated by 290 women | 3.4 Average rated by 62 women | 4.0 Good rated by 235 women |
Rating by Men Employees | 3.6 Good rated by 646 men | 4.0 Good rated by 1.6k men | 3.7 Good rated by 606 men | 3.8 Good rated by 557 men |
Job security | 3.3 Average | 3.8 Good | 3.3 Average | 3.9 Good |
View more
Biocon Biologics Salaries
Biocon Biologics salaries have received with an average score of 3.3 out of 5 by 834 employees.
Deputy Manager
(317 salaries)
Unlock
₹7.1 L/yr - ₹18 L/yr
Senior Scientist
(75 salaries)
Unlock
₹4.5 L/yr - ₹9.1 L/yr
Junior Executive
(66 salaries)
Unlock
₹2.7 L/yr - ₹5.3 L/yr
Principal Scientist
(52 salaries)
Unlock
₹5 L/yr - ₹14.6 L/yr
Executive Production
(47 salaries)
Unlock
₹3 L/yr - ₹5.6 L/yr
Scientist
(45 salaries)
Unlock
₹3.3 L/yr - ₹5.5 L/yr
Territory Business Manager
(45 salaries)
Unlock
₹4 L/yr - ₹8.9 L/yr
Associate Director
(44 salaries)
Unlock
₹23 L/yr - ₹50 L/yr
Executive Engineer
(33 salaries)
Unlock
₹3.8 L/yr - ₹6.3 L/yr
QC Executive
(26 salaries)
Unlock
₹3.7 L/yr - ₹6 L/yr
Biocon Biologics Jobs
Popular Designations Biocon Biologics Hires for
Corporate Finance
Create job alerts
Talent Acquisition Specialist
Create job alerts
Procurement Lead
Create job alerts
Current Openings
Biocon Biologics News
Stocks that will see action today: March 7, 2025
- Aarti Drugs received an Administrative Warning letter from SEBI for violation of Insider Trading Regulations, 2015.
- K&R Rail Engineering secured an order from Indian Port Rail and Ropeway Corporation Limited for projects ranging from Rs 50 to 5000 crore.
- IIFL Facilities Services purchased additional shares of Avanti Feeds for Rs 470 crore.
- NCLAT issued a notice to Ambuja Cements over a plea by Alok Sanghi regarding insolvency proceedings.
- Coromandel International opened a new sulphur manufacturing plant in Andhra Pradesh to double its capacity.
- BEL received additional orders worth ₹577 crore, bringing its total order book for FY25 to over ₹13,000 crore.
- Jay Bharat Maruti increased its shareholding in JBM OGIHARA Die-Tech to 49% by acquiring equity stake.
- KPIL secured new orders worth Rs 2,306 crore, increasing its total order book to Rs 22,500 crore.
- Laurus Labs approved investment of Rs 83.30 crore in joint venture KRKA Pharma for setting up a new manufacturing facility.
- Biocon Biologics collaborated with Civica Inc. to supply Insulin Aspart drug substance for enhancing access and affordability in the US.
HinduBusinessLine | 7 Mar, 2025
Stocks that will see action today: 25 February 2025
- Torrent Power's arm, Torrent Green Energy, has incorporated Torrent Urja 32 Pvt Ltd (TU32) to generate electricity from renewable energy.
- IREDA has received approval from its shareholders to raise up to ₹5,000 crore through issuance of equity shares to qualified institutional buyers.
- Life Insurance Corporation of India (LIC) has been slapped with a demand notice of about Rs 57.2 crore for excess Input Tax Credit (ITC) availed.
- Biocon Biologics has launched a biosimilar product to treat certain autoimmune diseases in the US market.
HinduBusinessLine | 25 Feb, 2025
Biocon Biologics sees diversified global expansion offsetting US localisation risks
- Biocon Biologics believes that its diversified global expansion will offset the risks of US localization.
- The company has witnessed sustained growth in the Mediterranean and UK-Nordics clusters, as well as positive traction in Japanese and Australian markets.
- Biocon Biologics aims to bring affordability and broaden access to patients in America, aligning with the US administration's focus on lowering healthcare costs.
- Biocon Biologics reported a 14% YoY growth in revenue for the Biosimilars segment and maintained stable market shares in Europe.
HinduBusinessLine | 1 Feb, 2025
CCI slaps ₹40 lakh fine on Goldman Sachs for failure to notify investment in Biocon Biologics
- Goldman Sachs has been fined ₹40 lakh by CCI for failure to notify its investment in Biocon Biologics.
- Goldman Sachs made the investment without seeking CCI approval, violating the Competition Act.
- CCI found that the investment granted Goldman Sachs strategic rights beyond those of ordinary shareholders.
- The ruling highlights the importance of compliance with competition laws in structuring minority investments.
HinduBusinessLine | 18 Jan, 2025
Biocon Biologics’ Bengaluru Facilities Get VAI Tag From US Drug Regulator
- The USFDA has issued a 'voluntary action indicated' (VAI) tag to Biocon Biologics' manufacturing facilities in Bengaluru.
- The inspection was carried out between July 15 and July 26 to assess good manufacturing practices.
- Objectionable conditions were found, but no administrative or regulatory action was recommended.
- Biocon Biologics remains committed to global standards of quality and compliance.
Bloomberg Quint | 10 Nov, 2024
Biocon Biologics Confident Of Tackling Pricing Pressures, Ready To Compete
- Biocon Biologics' Chief Executive Officer and Managing Director Shreehas Tambe is confident of tackling pricing pressures in the biosimilar market.
- Tambe emphasized that pricing is not a challenge for them, but rather a differentiator due to their competitive setup and cost structure.
- Biocon Biologics, as an emerging markets' player, focuses on a frugal cost structure and affordability index, driving the company's growth.
- Biocon Ltd., the parent company of Biocon Biologics, reported an over 84% decline in profit for the September quarter, while biosimilar sales were up 4%.
Bloomberg Quint | 5 Nov, 2024
Powered by
Biocon Biologics Offices
Compare Biocon Biologics with
LifeCell International
3.3
Praj Industries
4.1
Serum Institute of India
4.1
Bharat Biotech International
3.1
Transasia Bio-Medicals
3.2
Indian Immunologicals
4.0
Jubilant Biosys
3.8
Avantor
3.6
Aurigene Oncology Limited
4.3
Cryoviva Biotech
3.3
Novozymes South Asia
4.1
Biotique
3.5
dsm-firmenich
3.9
Kemwell Biopharma
3.6
Eurofins Scientific
3.3
Shivashakti Bio Technologies
4.3
Kemin Industries
4.2
Sartorius Stedim India
3.8
Pall Corporation
4.2
MilliporeSigma
4.0
Edit your company information by claiming this page
Contribute & help others!
You can choose to be anonymous
Companies Similar to Biocon Biologics
Biocon Limited
Biotech & Life sciences, Biotechnology
3.9
• 1.9k reviews
Thermo Fisher Scientific
Biotech & Life sciences, Internet, Analytics & KPO, Biotechnology, Pharma
3.8
• 839 reviews
Panacea Biotec
Biotech & Life sciences, Biotechnology
3.7
• 711 reviews
LifeCell International
Biotech & Life sciences, Internet, Biotechnology
3.3
• 642 reviews
Praj Industries
Biotech & Life sciences, Biotechnology
4.1
• 570 reviews
Serum Institute of India
Biotechnology
4.1
• 452 reviews
Bharat Biotech International
Biotech & Life sciences, Manufacturing, Biotechnology
3.1
• 444 reviews
Transasia Bio-Medicals
Industrial Machinery, Biotechnology
3.2
• 363 reviews
Indian Immunologicals
Biotech & Life sciences, Manufacturing, Biotechnology
4.0
• 353 reviews
Jubilant Biosys
Financial Services, Biotechnology
3.8
• 299 reviews
Avantor
Chemicals / Agri Inputs, Biotechnology, Healthcare, Pharma
3.6
• 268 reviews
Aurigene Oncology Limited
Biotech & Life sciences, Biotechnology
4.3
• 247 reviews
Biocon Biologics FAQs
When was Biocon Biologics founded?
Biocon Biologics was founded in 1978. The company has been operating for 47 years primarily in the Biotechnology sector.
Where is the Biocon Biologics headquarters located?
Biocon Biologics is headquartered in Bangalore/Bengaluru, Karnataka and has an office in Bangalore / Bengaluru
How many employees does Biocon Biologics have in India?
Biocon Biologics currently has more than 4,100+ employees in India. Production, Manufacturing & Engineering department appears to have the highest employee count in Biocon Biologics based on the number of reviews submitted on AmbitionBox.
Does Biocon Biologics have good work-life balance?
Biocon Biologics has a work-life balance rating of 3.3 out of 5 based on 800+ employee reviews on AmbitionBox. 37% employees rated Biocon Biologics 3 or below, while 63% employees rated it 4 or above for work-life balance. This rating suggests that while some employees recognize efforts towards work-life balance, there is scope for improvement based on employee feedback. We encourage you to read Biocon Biologics work-life balance reviews for more details
Is Biocon Biologics good for career growth?
Career growth at Biocon Biologics is rated as poor, with a promotions and appraisal rating of 2.9. 37% employees rated Biocon Biologics 3 or below on promotions/appraisal. This rating reflects a negative sentiment among employees for career growth. We recommend reading Biocon Biologics promotions/appraisals reviews for more detailed insights.
What are the cons of working in Biocon Biologics?
Working at Biocon Biologics does have some drawbacks that potential employees should consider. The company is poorly rated for promotions / appraisal, work satisfaction and work life balance, based on 800+ employee reviews on AmbitionBox.
Stay ahead in your career. Get AmbitionBox app
Helping over 1 Crore job seekers every month in choosing their right fit company
75 Lakh+
Reviews
5 Lakh+
Interviews
4 Crore+
Salaries
1 Cr+
Users/Month
Contribute to help millions
Get AmbitionBox app
Made with ❤️ in India. Trademarks belong to their respective owners. All rights reserved © 2024 Info Edge (India) Ltd.
Follow us
